News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
756,316 Results
Type
Article (50716)
Company Profile (305)
Press Release (705295)
Multimedia
Podcasts (108)
Webinars (13)
Section
Business (219776)
Career Advice (2573)
Deals (37458)
Drug Delivery (115)
Drug Development (85569)
Employer Resources (179)
FDA (17077)
Job Trends (16027)
News (370456)
Policy (35601)
Tag
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
Academia (2772)
Academic (1)
Accelerated approval (5)
Adcomms (22)
Allergies (92)
Alliances (54036)
ALS (97)
Alzheimer's disease (1438)
Antibody-drug conjugate (ADC) (140)
Approvals (17069)
Artificial intelligence (290)
Autoimmune disease (26)
Automation (16)
Bankruptcy (374)
Best Places to Work (12143)
BIOSECURE Act (21)
Biosimilars (115)
Biotechnology (195)
Bladder cancer (79)
Brain cancer (29)
Breast cancer (290)
Cancer (2353)
Cardiovascular disease (191)
Career advice (2165)
Career pathing (33)
CAR-T (158)
Cell therapy (458)
Cervical cancer (20)
Clinical research (69358)
Collaboration (890)
Compensation (541)
Complete response letters (26)
COVID-19 (2765)
CRISPR (48)
C-suite (256)
Cystic fibrosis (104)
Data (2245)
Decentralized trials (2)
Denatured (34)
Depression (46)
Diabetes (284)
Diagnostics (6653)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (132)
Drug pricing (118)
Drug shortages (29)
Duchenne muscular dystrophy (98)
Earnings (92304)
Editorial (44)
Employer branding (22)
Employer resources (154)
Events (122758)
Executive appointments (763)
FDA (18372)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (790)
Gene editing (116)
Generative AI (27)
Gene therapy (339)
GLP-1 (793)
Government (4854)
Grass and pollen (6)
Guidances (59)
Healthcare (19844)
Huntington's disease (24)
IgA nephropathy (31)
Immunology and inflammation (135)
Indications (30)
Infectious disease (2911)
Inflammatory bowel disease (146)
Inflation Reduction Act (10)
Influenza (52)
Intellectual property (99)
Interviews (443)
IPO (17077)
IRA (50)
Job creations (4325)
Job search strategy (1824)
Kidney cancer (10)
Labor market (38)
Layoffs (505)
Leadership (21)
Legal (8901)
Liver cancer (76)
Lung cancer (330)
Lymphoma (157)
Machine learning (7)
Management (61)
Manufacturing (327)
MASH (71)
Medical device (13956)
Medtech (13961)
Mergers & acquisitions (20940)
Metabolic disorders (740)
Multiple sclerosis (85)
NASH (21)
Neurodegenerative disease (104)
Neuropsychiatric disorders (30)
Neuroscience (2019)
NextGen: Class of 2025 (7005)
Non-profit (4805)
Now hiring (39)
Obesity (398)
Opinion (252)
Ovarian cancer (77)
Pain (95)
Pancreatic cancer (85)
Parkinson's disease (156)
Partnered (22)
Patents (244)
Patient recruitment (113)
Peanut (50)
People (61313)
Pharmaceutical (91)
Pharmacy benefit managers (21)
Phase I (21476)
Phase II (30378)
Phase III (22904)
Pipeline (1215)
Policy (164)
Postmarket research (2887)
Preclinical (9319)
Press Release (70)
Prostate cancer (113)
Psychedelics (34)
Radiopharmaceuticals (264)
Rare diseases (411)
Real estate (6545)
Recruiting (68)
Regulatory (24054)
Reports (47)
Research institute (2480)
Resumes & cover letters (414)
Rett syndrome (5)
RNA editing (5)
RSV (45)
Schizophrenia (76)
Series A (138)
Series B (89)
Service/supplier (14)
Sickle cell disease (58)
Special edition (17)
Spinal muscular atrophy (154)
Sponsored (31)
Startups (3859)
State (2)
Stomach cancer (15)
Supply chain (73)
Tariffs (45)
The Weekly (72)
Vaccines (746)
Venture capitalists (42)
Weight loss (275)
Women's health (37)
Worklife (17)
Date
Today (171)
Last 7 days (892)
Last 30 days (2761)
Last 365 days (34372)
2025 (11193)
2024 (36715)
2023 (41561)
2022 (52863)
2021 (57531)
2020 (56258)
2019 (49290)
2018 (37229)
2017 (34520)
2016 (34610)
2015 (40550)
2014 (34868)
2013 (30350)
2012 (32216)
2011 (32662)
2010 (31039)
Location
Africa (920)
Alabama (58)
Alaska (7)
Arizona (244)
Arkansas (14)
Asia (43325)
Australia (7119)
California (6257)
Canada (2037)
China (552)
Colorado (278)
Connecticut (295)
Delaware (151)
Europe (95547)
Florida (931)
Georgia (210)
Idaho (58)
Illinois (576)
India (28)
Indiana (320)
Iowa (11)
Japan (168)
Kansas (106)
Kentucky (24)
Louisiana (10)
Maine (64)
Maryland (929)
Massachusetts (4763)
Michigan (229)
Minnesota (395)
Mississippi (2)
Missouri (88)
Montana (27)
Nebraska (26)
Nevada (63)
New Hampshire (67)
New Jersey (1792)
New Mexico (30)
New York (1781)
North Carolina (1052)
North Dakota (9)
Northern California (2711)
Ohio (211)
Oklahoma (15)
Oregon (39)
Pennsylvania (1399)
Puerto Rico (13)
Rhode Island (34)
South America (1311)
South Carolina (22)
South Dakota (1)
Southern California (2354)
Tennessee (103)
Texas (923)
United States (23903)
Utah (184)
Virginia (160)
Washington D.C. (63)
Washington State (571)
West Virginia (3)
Wisconsin (63)
756,316 Results for "p and g pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
April 29, 2025
·
3 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
April 2, 2025
·
2 min read
Biotech Bay
Talphera to Participate at A.G.P. Virtual Healthcare Conference
Talphera, Inc. (Nasdaq: TLPH), (“Talphera”), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that management will participate in a fireside chat at the A.G.P. Virtual Healthcare conference May 21, 2024 at 10:40 a.m. ET.
May 16, 2024
·
1 min read
Pharm Country
Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
Tonix Pharmaceuticals Holding Corp. announced today that Seth Lederman, M.D., Chief Executive Officer, will participate virtually in a fireside chat at A.G.P.’s Healthcare Company Showcase on Tuesday, May 21, 2024, at 9:00 a.m. ET.
May 15, 2024
·
3 min read
Press Releases
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors
April 21, 2025
·
4 min read
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
Fortress Biotech, Inc. today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company.
May 16, 2024
·
1 min read
Biotech Bay
RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024
RenovoRx, Inc. announced that Shaun Bagai, Chief Executive Officer, will participate in a fireside chat at Alliance Global Partners Virtual Healthcare Company Showcase hosted by Scott Henry, Managing Director and Healthcare Analyst at A.G.P.
May 14, 2024
·
7 min read
Press Releases
Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time
April 29, 2025
·
1 min read
Press Releases
BIOQUAL Announces the retirement of Dr. Mark G. Lewis as President and CEO of the company
May 1, 2025
·
2 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
1 of 75,632
Next
